Appeals Court Allows Tylenol Lawsuits to Proceed; Carlson Law Firm Accepting Clients

KILLEEN, Texas – A federal appeals court has granted a significant legal victory for hundreds of families filing lawsuits related to Tylenol use during pregnancy. On July 13, the 2nd U.S. Circuit Court of Appeals vacated a prior lower court decision that had dismissed over 500 cases.

These lawsuits allege that prenatal exposure to acetaminophen, the active ingredient in Tylenol, contributed to the development of neurodevelopmental disorders in children, including ADHD and autism spectrum disorder. The Carlson Law Firm announced it is now accepting new clients for these cases.

The appeals court ruling allows the litigation to proceed by finding that the scientific methodologies used by the families' experts are sufficiently reliable to be presented in court. However, the decision does not determine that Tylenol causes these conditions, focusing instead on the admissibility of expert testimony.

"The 2nd Circuit's decision acknowledges that the plaintiffs' experts have a sound basis to testify about the alleged connection between acetaminophen use during pregnancy and the risk of autism or ADHD," said Ruth Rizkalla, a partner at The Carlson Law Firm. "This decision allows mothers and their children to move forward with their claims against the makers of Tylenol and other retailers."

The cases have been returned to the district court for further proceedings. No liability or settlement has been determined, and neither the manufacturers' nor sellers' responsibility for Tylenol has been proven. The Carlson Law Firm continues to handle these cases, assisting families through the legal process.